Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Jae Keith Joung, M.D.,Ph.D.

Co-Author

This page shows the publications co-authored by Jae Joung and Martin Aryee.
Connection Strength

2.709
  1. Augmenting and directing long-range CRISPR-mediated activation in human cells. Nat Methods. 2021 09; 18(9):1075-1081.
    View in: PubMed
    Score: 0.244
  2. Publisher Correction: Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing. Nat Biotechnol. 2020 Jul; 38(7):901.
    View in: PubMed
    Score: 0.226
  3. A dual-deaminase CRISPR base editor enables concurrent adenine and cytosine editing. Nat Biotechnol. 2020 07; 38(7):861-864.
    View in: PubMed
    Score: 0.225
  4. CRISPR DNA base editors with reduced RNA off-target and self-editing activities. Nat Biotechnol. 2019 09; 37(9):1041-1048.
    View in: PubMed
    Score: 0.214
  5. Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors. Nature. 2019 05; 569(7756):433-437.
    View in: PubMed
    Score: 0.208
  6. Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing. Nat Biotechnol. 2019 03; 37(3):276-282.
    View in: PubMed
    Score: 0.206
  7. In vivo CRISPR editing with no detectable genome-wide off-target mutations. Nature. 2018 09; 561(7723):416-419.
    View in: PubMed
    Score: 0.200
  8. CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR-Cas9 nuclease off-targets. Nat Methods. 2017 Jun; 14(6):607-614.
    View in: PubMed
    Score: 0.182
  9. Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells. Nat Biotechnol. 2016 08; 34(8):869-74.
    View in: PubMed
    Score: 0.171
  10. Open-source guideseq software for analysis of GUIDE-seq data. Nat Biotechnol. 2016 05 06; 34(5):483.
    View in: PubMed
    Score: 0.170
  11. Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature. 2015 Jul 23; 523(7561):481-5.
    View in: PubMed
    Score: 0.160
  12. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat Biotechnol. 2015 Feb; 33(2):187-197.
    View in: PubMed
    Score: 0.154
  13. Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing. Nat Biotechnol. 2014 Jun; 32(6):569-76.
    View in: PubMed
    Score: 0.147
  14. High levels of AAV vector integration into CRISPR-induced DNA breaks. Nat Commun. 2019 09 30; 10(1):4439.
    View in: PubMed
    Score: 0.054
  15. Defining CRISPR-Cas9 genome-wide nuclease activities with CIRCLE-seq. Nat Protoc. 2018 11; 13(11):2615-2642.
    View in: PubMed
    Score: 0.050
  16. Activities and specificities of CRISPR/Cas9 and Cas12a nucleases for targeted mutagenesis in maize. Plant Biotechnol J. 2019 02; 17(2):362-372.
    View in: PubMed
    Score: 0.049
  17. Response to "Unexpected mutations after CRISPR-Cas9 editing in vivo". Nat Methods. 2018 04; 15(4):238-239.
    View in: PubMed
    Score: 0.048
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.